Immunodiagnostic Systems Hldgs PLC Director/PDMR Shareholding (6655D)
February 20 2020 - 11:49AM
UK Regulatory
TIDMIDH
RNS Number : 6655D
Immunodiagnostic Systems Hldgs PLC
20 February 2020
Immunodiagnostic Systems Holdings plc
Director Dealing
20 February 2020
Immunodiagnostic Systems Holdings plc (IDH.L) ("IDS" or the
"Company"), a specialist producer of manual and automated
diagnostic testing kits and instrumentation for the clinical and
research markets, was advised that today, Jaap Stuut, Chief
Executive Officer, acquired 2,500 ordinary shares of 2p each
("Ordinary Shares") in the Company at an average price of GBP2.10
per Ordinary Share.
Following these purchases, Mr Stuut is interested in 7,500
Ordinary Shares, 0.03% of the issued share capital of the
Company.
For further information:
Immunodiagnostic Systems Holdings Tel : +44 (0)191 519 0660
plc
Paul Martin, Group Finance Director
Peel Hunt LLP Tel : +44 (0)207 418 8900
James Steel
Oliver Jackson
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name Jaap Stuut
------------------------------- -----------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------------
a. Position/status Chief Executive Officer
------------------------------- -----------------------------------------------
b. Initial notification Initial
/Amendment
------------------------------- -----------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------
a. Name Immunodiagnostic Systems Holdings plc
------------------------------- -----------------------------------------------
b. LEI 213800HZMYTD4NGF4L78
------------------------------- -----------------------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------
a. Description of Ordinary shares of 2p each in Immunodiagnostic
the Systems Holdings plc
Financial instrument, Ordinary shares
type of instrument GB00B01YZ052
Identification
code
------------------------------- -----------------------------------------------
b. Nature of the Purchase
transaction
------------------------------- -----------------------------------------------
c. Price(s) and Price(s) Volume(s)
volume(s) GBP2 .10 2,500
----------
------------------------------- -----------------------------------------------
d. Aggregated information
* Aggregated volume N/A
* Price
------------------------------- -----------------------------------------------
e. Date of the transaction 2 020-02-20
------------------------------- -----------------------------------------------
f. Place of the London Stock Exchange, AIM
transaction
------------------------------- -----------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBLGDDLSDDGGG
(END) Dow Jones Newswires
February 20, 2020 11:49 ET (16:49 GMT)
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Jul 2023 to Jul 2024